✦ LIBER ✦

Bone graft substitutes

✍ Scribed by T. W. Bauer

Publisher: Springer
Year: 2007
Tongue: English
Weight: 62 KB
Volume: 36
Category: Article
ISSN: 0364-2348
DOI: 10.1007/s00256-007-0377-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthetic bone graft substitutes

✍ William R. Moore; Stephen E. Graves; Gregory I. Bain 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Replacement of extensive local bone loss is a significant clinical challenge. There are a variety of techniques available to the surgeon to manage this problem, each with their own advantages and disadvantages. It is well known that there is morbidity associated with harvesting of autogenous bone gr

Osteoinductive bone graft substitutes

✍ T. Steffen; A. Tsantrizos; I. Fruth; M. Aebi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 75 KB

Mediation of bone ingrowth in porous hyd

Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes

✍ Hing, Karin A. ;Best, Serena M. ;Tanner, K. Elizabeth ;Bonfield, William ;Revell 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

## Abstract Previous investigations have shown that both the early biological response and the mechanical properties of a porous hydroxyapatite bone graft substitute are highly sensitive to its pore structure. The objective of this study was to evaluate whether the pore structure continued to influ

Buchbesprechung: Bone Graft Substitutes.

Buchbesprechung: Bone Graft Substitutes. C. T. Laurencin (ed.)

✍ G. Willmann 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

Bone graft substitutes in anterior cervi

Bone graft substitutes in anterior cervical discectomy and fusion

✍ Anthony M. T. Chau; Ralph J. Mobbs 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 370 KB

Bioactive glass and autogenous bone as b

Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors

✍ Nina C. Lindfors; Jouni T. Heikkilä; Ilona Koski; Kimmo Mattila; Allan J. Aho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract In a prospective randomized study, 25 patients with benign bone tumors were surgically treated with either bioactive glass S53P4 (BG) or autogenous bone (AB) as bone graft material. X‐rays were taken preoperatively and postoperatively at 2 weeks and at 3, 8, 12, 18, 24, and 36 months. I